During the past decade, Baylor Scott and White Research Institute - Hematology/Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor Scott and White Research Institute - Hematology/Oncology" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Baylor Scott and White Research Institute - Hematology/Oncology" are "Indolent Non-hodgkin Lymphoma" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Baylor Scott and White Research Institute - Hematology/Oncology" in a lesser frequency.

Most popular intervention types in "Baylor Scott and White Research Institute - Hematology/Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Duvelisib" (1 trials), "Nivolumab" (1 trials) and "Tivozanib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor Scott and White Research Institute - Hematology/Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Baylor Scott and White Research Institute - Hematology/Oncology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Baylor Scott and White Research Institute - Hematology/Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baylor Scott and White Research Institute - Hematology/Oncology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".